Skip to main content
. Author manuscript; available in PMC: 2014 May 19.
Published in final edited form as: Ann Surg Oncol. 2013 Jun 28;20(11):3484–3490. doi: 10.1245/s10434-013-3076-5

Table 3.

Follow-up Data of Bethesda Categories III/IV vs. V/VI

Bethesda Category
N=360 III or IV (n=73) V or VI (n=287) p-value
Length of follow-up (months)1 20 (0.5–97) 20 (0.5–105) 0.973
% Radioactive Iodine 43 (59%) 199 (69%) 0.082
131I dose (mCi)1 51 (0–446) 75 (0–353) 0.092
Recurrence 2 (3%) 21 (7%) 0.152
Time to recurrence (months)1 12 (0–24) 10 (0–60) 0.912
Overall survival 99% 99% 1.000
1

Median (range).